특허 Jay wilson

[마운틴듀2]

https://www.facebook.com/share/v/1KHK7AXRan/

Facebook

US9443061B2, titled “Devices and methods for recording information on a subject’s body,” describes a system for placing a visible or invisible information mark on or under a person’s skin at the time they receive a medical treatment, then reading that mark later to retrieve medical information. The patent was filed in 2011 and granted in 2016.

In simple terms, the invention combines two things: administering a treatment—such as a drug or vaccine—and administering a coded physical mark that records information about that treatment. The patent specifically describes delivery methods including ordinary needles, microneedles, microneedle arrays, inhalers, transdermal patches, inkjet injectors, and needle-free injectors. The information mark can be placed on the skin or below it.

One of the most notable examples in the patent involves quantum-dot microbeads. It describes a child receiving an MMR vaccination and then receiving quantum-dot-containing microbeads through a microneedle array. Those markings could encode information such as the vaccination date, healthcare worker, location, vaccine identity, manufacturer, and lot number. The patent says the quantum dots could then be illuminated and detected with a spectrofluorometer, with the resulting spectral information compared against stored computer data.

The patent is not limited to quantum dots. It discusses marks that may be fluorescent, magnetic, electrically conductive, optically readable, RFID-related, particle-based, or formed from dielectric materials. Some marks could be invisible to the naked eye. The patent also describes patterns—essentially physical codes—that could represent stored information.

Another embodiment describes a microwave-readable dielectric barcode placed on or in the skin. The patent discusses a dielectric pattern encoding information such as a person's identity and vaccination information and describes interrogating such a pattern with electromagnetic radiation around the terahertz range. The detected information could then be decoded and transmitted to a computer.

The computer side of the system is important. The mark is not necessarily supposed to contain an entire medical record by itself. It can contain identifying or treatment information that is read by a sensor and then associated with an electronic database or health record. The patent describes systems that could use information obtained from the mark to decide whether another treatment should be administered—or whether treatment should be withheld.

The patent also discusses wireless communication. One embodiment has electronic circuitry and a wireless communications system capable of sending information to another device, computer system, or electronic registry. It also describes tracking whether a person complied with medication administration.

A particularly unusual part of the description involves vaccination verification and incentives. It gives examples in which information marks identify people who received a vaccination, and those marks could entitle them to rewards. The patent even describes a hypothetical system where a remote reader in places such as an airport, clinic, school, library, or shopping mall could detect a person's information mark. One example says an insurance company could receive vaccination-status information and provide credits or other rewards.

Claim 1 centers on a system containing a treatment-delivery mechanism, a programmable microneedle array connected to at least two reservoirs of microbead suspensions, an information-mark reader, and computing circuitry capable of determining subsequent medical treatment based on a previously administered information mark. The dependent claims cover things such as optical readers, patterns of multiple marks, subject-specific information, previous treatment information, biometric/personal information, and magnetic, colored, or polymeric particles.

So, stripped down to its basic concept, this patent describes:

1. Give a person a medical treatment.

2. Place a coded physical mark on or beneath their skin at approximately the same time.

3. Use particles, microbeads, quantum dots, magnetic materials, dielectric materials, or similar technologies to form the mark.

4. Read the mark later with an optical, electromagnetic, magnetic, or electronic reader.

5. Connect that information with a computer/ database containing medical information.

6. Potentially use the information to verify treatment history, guide future treatment, monitor compliance, or establish eligibility for incentives/rewards.

The concepts of microneedle-administered information marks, quantum-dot microbeads, machine-readable skin markings, medical-record linkage, and vaccination verification are explicitly described in the patent itself.

Devices and methods for recording information on a subject's body
https://patents.google.com/patent/US9443061B2/en